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 PROGESTERONE VAGINAL RING  
PREVENTS PREGNANCY 
  
Vaginal rings are a novel way of delivering 
contraceptives. The Progesterone  
Vaginal Ring (PVR) is a vaginal ring which 
contains progesterone and can prevent 
pregnancy.   
 
The PVR has clinically been proven to be a safe and effective 
method of contraception for lactating women. When used by  
lactating women it prevents pregnancy in a number of ways. It:  
• Inhibits follicular growth and hence prevents ovulation.  
• Reinforces the inhibitory effect of breastfeeding on  
ovulation.  
• Extends postpartum amenorrhea. 
• Thickens the cervical mucus, thus inhibiting sperm from  
meeting the egg. 
 
THE EVIDENCE 
The effectiveness of the PVR in preventing pregnancy has been 
demonstrated in three key areas:  
 
PREVENTION OF OVULATION 
A complex system of communication from the hypothalamus  
to the pituitary to the ovaries governs ovulation. This commu-
nication system regulates the production of two hormones— 
the Follicle-Stimulating Hormone (FSH) and the Luteinizing 
Hormone (LH)—that are key for informing the ovaries to pro-
duce and release an egg. In a menstrual cycle, the effect of 
FSH is to grow follicles to house an egg and for LH to initiate 
release of the egg into the Fallopian tube. LH also sends sig-
nals to produce progesterone and to prepare the endometrium 
for a possible pregnancy. Progesterone’s role is to inhibit the 
development of a new follicle. If the egg is not fertilized, pro-
gesterone levels drop after 14 days and the endometrium 
breaks down and the next menstrual bleeding occurs. 
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REINFORCEMENT OF THE EFFECT OF  
BREASTFEEDING ON OVULATION 
Breastfeeding too plays a role in delaying the resumption 
of normal ovarian cycles after delivery. The baby’s suck-
ling at its mother’s breast suppresses the production of 
FSH and LH required for ovulation (McNeilly, Tay and 
Glasier, 1994; McNeilly, 1997). We know that suckling 
sets off a chain reaction of signals from the hypothalamus 
to the pituitary to the ovaries thereby regulating ovulation. 
As the baby nurses less as it grows the suckling response 
fades. As the suckling response reduces, FSH and LH re-
sume their normal levels and signaling processes, sus-
tainable follicles develop, and ovulation occurs.  
 
EXTENSION OF LACTATIONAL AMENORRHEA  
Lactational amenorrhea is the natural infertility that occurs 
immediately after childbirth. How long a woman is amenor-
rhic depends on how long and how frequently she breast-
feeds. The duration of breastfeeding depends on a number 
of factors including a mother’s ability to breastfeed, her in-
terest in doing so, and the timing of introduction of weaning 
foods. Higher rates of amenorrhea have been observed 
among PVR users than IUD users in a comparative trial of 
the two methods; amenorrhea on average is five months 
longer (cited in Massai et al. 2000).  
 
EXPANDING CONTRACEPTIVE OPTIONS 
In 2015, the PVR has been added to the World Health Or-
ganization’s (WHO) Essential Medicines List (EML) and  
Medical Eligibility Criteria (MEC) for Contraceptive Use guid-
ance for providers.  
 
SUMMARY 
The PVR expands the range of contraceptives available to 
lactating women. It has been proven to be safe and effec-
tive. It has the potential to contribute to improving maternal 
and infant health. 
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THE PVR WORKS BY: 
• Delivering a small quantity of progesterone 
acting both on ovulation and cervical mucus. 
The progesterone in the ring is diffused into 
the vaginal walls and then into the blood 
stream. 
• reinforcing the effect of the baby’s suckling 
on the mother’s production of the Follicle-
Stimulating Hormone (FSH) and the Luteiniz-
ing Hormone (LH). The effect of suckling on 
the hypothalamus-pituitary ovarian re-
sponse results in the suppression of FSH 
and LH. In turn, the reduced levels of FSH 
and LH causes a delay in ovulation. 
• increasing the prolactin response to suck-
ling. Prolactin is the hormone that stimu-
lates and maintains the production of milk, 
and progesterone enhances prolactin pro-
duction. Mothers are therefore able to nurse 
her baby for longer than otherwise possible, 
and longer breastfeeding durations extend 
the postpartum amenorrheic period. 
 
 
SOURCES: Diaz et al. 1991; McNeilly, Tay and Glasier 1994; 
Labbok 2008; Simpson-Herbert and Huffman 1981.) 
 
 
 
